BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1425020)

  • 1. Regulation of leukaemic cells by interleukin 6 and leukaemia inhibitory factor.
    Lotem J; Sachs L
    Ciba Found Symp; 1992; 167():80-8; discussion 88-99. PubMed ID: 1425020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncostatin M is a differentiation factor for myeloid leukemia cells.
    Bruce AG; Hoggatt IH; Rose TM
    J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal variation in susceptibility to differentiation by different protein inducers in the myeloid leukemia cell line M1.
    Lotem J; Shabo Y; Sachs L
    Leukemia; 1989 Nov; 3(11):804-7. PubMed ID: 2509827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of macrophage differentiation in response to leukemia inhibitory factor/oncostatin-M/interleukin-6: the effect of enforced expression of the SCL transcription factor.
    Tanigawa T; Nicola N; McArthur GA; Strasser A; Begley CG
    Blood; 1995 Jan; 85(2):379-90. PubMed ID: 7811994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
    Piekorz RP; Hocke GM
    Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: role in growth inhibition.
    Abdollahi A; Lord KA; Hoffman-Liebermann B; Liebermann DA
    Cell Growth Differ; 1991 Aug; 2(8):401-7. PubMed ID: 1793735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro expansion of murine hematopoietic progenitor cells by leukemia inhibitory factor, stem cell factor, and interleukin-1 beta.
    Imamura M; Zhu X; Han M; Kobayashi M; Hashino S; Tanaka J; Kobayashi S; Kasai M; Asaka M
    Exp Hematol; 1996 Sep; 24(11):1280-8. PubMed ID: 8862438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The induction and inhibition of differentiation in normal and leukaemic cells.
    Metcalf D
    Philos Trans R Soc Lond B Biol Sci; 1990 Mar; 327(1239):99-109. PubMed ID: 1690902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced suppression of human myeloid leukemic cell lines by combinations of IL-6, LIF, GM-CSF and G-CSF.
    Maekawa T; Metcalf D; Gearing DP
    Int J Cancer; 1990 Feb; 45(2):353-8. PubMed ID: 1689277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of differentiation-inducing factor and other cytokines on induction of differentiation of mouse myeloid leukemic cells.
    Yamamoto-Yamaguchi Y; Tomida M; Hozumi M; Maurer HR; Okabe T; Takaku F
    Jpn J Cancer Res; 1989 Feb; 80(2):115-21. PubMed ID: 2470711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal analysis of the actions of the murine leukemia inhibitory factor on leukemic and normal murine hemopoietic cells.
    Metcalf D; Hilton DJ; Nicola NA
    Leukemia; 1988 Apr; 2(4):216-21. PubMed ID: 2452326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of leukemia inhibitory factor and interleukin 6 on the growth of acute myeloid leukemia cells.
    Takanashi M; Motoji T; Masuda M; Oshimi K; Mizoguchi H
    Leuk Res; 1993 Mar; 17(3):217-22. PubMed ID: 8095566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient expression of the IL-2 receptor alpha-chain in IL-6-induced myeloid cells is regulated by autocrine production of prostaglandin E2.
    Ruhl S; Begley CG; Bickel M; Pluznik DH
    Exp Hematol; 1992 Jun; 20(5):619-25. PubMed ID: 1587308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
    Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
    Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pleiotropic actions of leukemia inhibitory factor.
    Gough NM; Williams RL
    Cancer Cells; 1989 Nov; 1(3):77-80. PubMed ID: 2518284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo control of differentiation of myeloid leukemic cells by cyclosporine A and recombinant interleukin-1 alpha.
    Lotem J; Sachs L
    Blood; 1988 Nov; 72(5):1595-601. PubMed ID: 2460157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine flt3 ligand protects M1 leukemic cells from LIF-induced differentiation and suppression of self-renewal.
    Begley CG; Rasko JE; Curtis D; Takagi K; Metcalf D; Hilton D; Roberts B; Nicola NA; Rossner MT
    Exp Hematol; 1996 Aug; 24(10):1247-57. PubMed ID: 8765501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions and interactions of G-CSF, LIF, and IL-6 on normal and leukemic murine cells.
    Metcalf D
    Leukemia; 1989 May; 3(5):349-55. PubMed ID: 2469911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-4 inhibits the differentiation of mouse myeloid leukemia M1 cells induced by dexamethasone, D-factor/leukemia inhibitory factor and interleukin-6, but not by 1 alpha,25-dihydroxyvitamin D3.
    Kasukabe T; Okabe-Kado J; Honma Y; Hozumi M
    FEBS Lett; 1991 Oct; 291(2):181-4. PubMed ID: 1936261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cytotoxicity and differentiation-inducing potential of arabinofuranosylcytosine in myeloid leukemia cells by hematopoietic cytokines.
    Brach MA; Mertelsmann RH; Herrmann F
    Cancer Invest; 1993; 11(2):198-211. PubMed ID: 8462021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.